A light-emitting device includes: a light-emitting element configured to emit first light; a light-transmissive member covering an upper surface of the light-emitting element and including a wavelength conversion material configured to absorb a portion of the first light and emit second light; a light-scattering member disposed on the light-transmissive member, including a light-scattering material, and having a higher reflectance at a peak wavelength of the first light than at a peak wavelength of the second light; and a light-adjustment member located in or on the light-scattering member and having either (i) a higher absorptance at the peak wavelength of the second light than at the peak wavelength of the first light, or (ii) a higher reflectance at the peak wavelength of the second light than at the peak wavelength of the first light. A lateral surface of the light-transmissive member is exposed from the light-scattering member and the light-adjustment member.

Described are methods of preparing precursor cell-derived induced pluripotent stem cells (iPSCs) and methods of generating iPSC-derived gd T-cells. The invention also includes cell populations comprising the iPSCs, cell populations comprising the iPSC-derived gd T-cells, pharmaceutical compositions comprising the cell populations, and methods of treating cancer comprising administration of the cell population or pharmaceutical composition thereof.